A study has shown that the TNFSF13B antibody improved atherosclerosis lesions in mice with low plasma cholesterol levels but worsened the lesions in mice with high cholesterol levels, further indicating the diverse effect of TNFSF13B (Saidoune et al., 2021). This evidence concerns the gene TNFSF13B and atherosclerosis.